Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

413 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features.
Magaret C, Li L, deCamp A, Rolland M, Juraska M, Williamson B, Ludwig J, Molitor C, Benkeser D, Luedtke A, Simpkins B, Carpp L, Bai H, Deariove B, Greninger A, Roychoudhury P, Sadoff J, Gray G, Roels S, Vandebosch A, Stieh D, Le Gars M, Vingerhoets J, Grinsztejn B, Goepfert P, Truyers C, Van Dromme I, Swann E, Marovich M, Follmann D, Neuzil K, Corey L, Hyrien O, Paiva de Sousa L, Casapia M, Losso M, Little S, Gaur A, Bekker LG, Garrett N, Heng F, Sun Y, Gilbert P. Magaret C, et al. Among authors: greninger a. Res Sq [Preprint]. 2023 May 31:rs.3.rs-2743022. doi: 10.21203/rs.3.rs-2743022/v1. Res Sq. 2023. Update in: Nat Commun. 2024 Mar 11;15(1):2175. doi: 10.1038/s41467-024-46536-w PMID: 37398105 Free PMC article. Updated. Preprint.
Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Subvariant Neutralization Following a Primary Vaccine Series of NVX-CoV2373 and BNT162b2 Monovalent Booster Vaccine.
Babu TM, Shen X, McClelland RS, Wang Z, Selke S, Wilkens C, Hauge KA, McClurkan CL, Goecker E, Laing KJ, Koelle DM, Greninger AL, Nussenzweig MC, Montefiori DC, Corey L, Wald A. Babu TM, et al. Among authors: greninger al. Open Forum Infect Dis. 2024 Jan 3;11(2):ofad673. doi: 10.1093/ofid/ofad673. eCollection 2024 Feb. Open Forum Infect Dis. 2024. PMID: 38379566 Free PMC article.
Nebulized fusion inhibitory peptide protects cynomolgus macaques from measles virus infection.
Reynard O, Gonzalez C, Dumont C, Iampietro M, Ferren M, Le Guellec S, Laurie L, Mathieu C, Carpentier G, Roseau G, Bovier FT, Zhu Y, Le Pennec D, Montharu J, Addetia A, Greninger AL, Alabi CA, Moscona A, Vecellio L, Porotto M, Horvat B. Reynard O, et al. Among authors: greninger al. Res Sq [Preprint]. 2022 Jun 1:rs.3.rs-1700877. doi: 10.21203/rs.3.rs-1700877/v1. Res Sq. 2022. Update in: Nat Commun. 2022 Oct 28;13(1):6439. doi: 10.1038/s41467-022-33832-6 PMID: 35677066 Free PMC article. Updated. Preprint.
Age-dependent heterogeneity in the antigenic effects of mutations to influenza hemagglutinin.
Welsh FC, Eguia RT, Lee JM, Haddox HK, Galloway J, Van Vinh Chau N, Loes AN, Huddleston J, Yu TC, Quynh Le M, Nhat NTD, Thi Le Thanh N, Greninger AL, Chu HY, Englund JA, Bedford T, Matsen FA 4th, Boni MF, Bloom JD. Welsh FC, et al. Among authors: greninger al. Cell Host Microbe. 2024 Aug 14;32(8):1397-1411.e11. doi: 10.1016/j.chom.2024.06.015. Epub 2024 Jul 19. Cell Host Microbe. 2024. PMID: 39032493 Free article.
Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024.
Moline HL, Toepfer AP, Tannis A, Weinberg GA, Staat MA, Halasa NB, Boom JA, Klein EJ, Williams JV, Schuster JE, Goldstein L, McKeever ER, Kalman C, Paden C, Atherton L, Aggarwal M, Roychoudhury P, Piedra PA, Sahni LC, Stewart LS, Selvarangan R, Michaels MG, Schlaudecker EP, Szilagyi PG, Englund JA, Clopper BR, Thornburg NJ, Derado G, McMorrow ML, Dawood FS; New Vaccine Surveillance Network Collaborators. Moline HL, et al. JAMA Pediatr. 2024 Dec 9:e245572. doi: 10.1001/jamapediatrics.2024.5572. Online ahead of print. JAMA Pediatr. 2024. PMID: 39652359
Early antiviral CD4+ and CD8+ T cells are associated with upper airway clearance of SARS-CoV-2.
Ramirez SI, Lopez PG, Faraji F, Parikh UM, Heaps A, Ritz J, Moser C, Eron JJ, Wohl D, Currier J, Daar ES, Greninger A, Klekotka P, Grifoni A, Weiskopf D, Sette A, Peters B, Hughes MD, Chew KW, Smith DM, Crotty S; Accelerating COVID-19 Therapeutic Interventions and Vaccines-2 (ACTIV-2)/A5401 Study Team. Ramirez SI, et al. Among authors: greninger a. JCI Insight. 2024 Dec 20;9(24):e186078. doi: 10.1172/jci.insight.186078. JCI Insight. 2024. PMID: 39704169 Free PMC article.
Prospective, multi-site evaluation of the Cepheid Xpert Xpress CoV-2 plus test on nasal and nasopharyngeal swabs.
Greninger AL, Larcena A, Patel A, Webster B, Ulen C, Green DF, King D, Patel DR, McElvania E, Harnett G, Jandali I, Gibson J, Killion J, Atwi J, Bergmann K, Slade L, Allen Staat M, Faron M, Washington M, Patel R, Annamalai R, Ackerman R, Stewart WP 3rd, Amador YM, Rao D, Liu X, Raman A. Greninger AL, et al. J Clin Microbiol. 2024 Dec 11;62(12):e0121924. doi: 10.1128/jcm.01219-24. Epub 2024 Nov 6. J Clin Microbiol. 2024. PMID: 39503494 Free PMC article.
413 results